Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127120182 | 12712018 | 2 | F | 20160715 | 20160829 | 20160902 | 20160908 | EXP | JP-FRI-1000087076 | FOREST | 50.00 | YR | F | Y | 0.00000 | 20160908 | OT | US | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127120182 | 12712018 | 1 | PS | ASENAPINE | ASENAPINE | 1 | Sublingual | 10 MG | Y | 22117 | 5 | MG | BID | ||||||
| 127120182 | 12712018 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG | Y | 21323 | 20 | MG | QD | ||||||
| 127120182 | 12712018 | 3 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 100 MG | Y | N | 0 | 100 | MG | QD | |||||
| 127120182 | 12712018 | 4 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 175 MG | Y | N | 0 | 175 | MG | QD | |||||
| 127120182 | 12712018 | 5 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 300 MG | Y | N | 0 | 300 | MG | QD | |||||
| 127120182 | 12712018 | 6 | C | TANDOSPIRONE CITRATE | TANDOSPIRONE CITRATE | 1 | 0 | ||||||||||||
| 127120182 | 12712018 | 7 | C | BROTIZOLAM | BROTIZOLAM | 1 | 0 | ||||||||||||
| 127120182 | 12712018 | 8 | C | SUVOREXANT. | SUVOREXANT | 1 | 0 | TABLET | |||||||||||
| 127120182 | 12712018 | 9 | C | YOKU-KAN-SAN | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127120182 | 12712018 | 1 | Schizophrenia |
| 127120182 | 12712018 | 2 | Generalised anxiety disorder |
| 127120182 | 12712018 | 3 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127120182 | 12712018 | OT |
| 127120182 | 12712018 | HO |
| 127120182 | 12712018 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127120182 | 12712018 | Oculogyric crisis | |
| 127120182 | 12712018 | Protrusion tongue | |
| 127120182 | 12712018 | Seizure | |
| 127120182 | 12712018 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127120182 | 12712018 | 1 | 20160714 | 20160715 | 0 | |
| 127120182 | 12712018 | 2 | 20160616 | 20160715 | 0 | |
| 127120182 | 12712018 | 3 | 20160704 | 0 | ||
| 127120182 | 12712018 | 4 | 20160706 | 20160714 | 0 | |
| 127120182 | 12712018 | 5 | 20160726 | 0 | ||
| 127120182 | 12712018 | 6 | 20160707 | 20160715 | 0 | |
| 127120182 | 12712018 | 7 | 2016 | 0 | ||
| 127120182 | 12712018 | 8 | 20160620 | 0 | ||
| 127120182 | 12712018 | 9 | 20160609 | 0 |